$7.59
0.070.93%
At Close: -
$7.59
00.00%
After Hours: 4:00 PM EDT
15 minutes delayed
Sage Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Sage Therapeutics using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-07-31 | $-1.70 | $-1.66 | -2.41 % |
Mar 2024 | 2024-04-25 | $-1.80 | $-1.65 | -9.09 % |
Dec 2023 | 2024-02-14 | $-0.55 | $-1.28 | 57.0 % |
Sep 2023 | 2023-11-07 | $-3.37 | $-2.73 | -23.4 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-07-31 | $8.65M | $8.85M | -2.19 % |
Mar 2024 | 2024-04-25 | $7.90M | $5.66M | 39.6 % |
Dec 2023 | 2024-02-14 | $77.97M | $60.98M | 27.9 % |
Sep 2023 | 2023-11-07 | $2.72M | $4.62M | -41.2 % |
Sage Therapeutics (SAGE) is scheduled to report earnings on November 5, 2024. The last reported earnings were for reported on July 31, 2024 for Q2.
The Actual EPS was $-1.70, which missed the estimate of $-1.66.
The Actual Revenue was $8.7M, which missed the estimate of $8.8M.
Browse earnings estimates, EPS, and revenue on all stocks.